The problem of what effect BCG vaccination would have on individuals who are exposed to leprosy and may be infected but in whom no signs are yet apparent, is highly important and those studies were conducted in an attempt to clarify this. As a model experiment, 100 rats were first inoculated subcutaneously with murine leprosy bacilli and infected and BCG or an attenuated tubercle bacilli vaccine were then injected intraperitoneally after 1 day, 2 weeks, 4 weeks or 8 weeks.
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The effect of infection on murine leprosy was examined and the following results were observed.
1) The growth and weight gain of the leproma was slower in the group in which BCG was injected in 1 day after infection, compared with the untreated control. The leproma in 2 and 4 weeks on BCG injected groups was also somewhat smaller, but there was almost no effect in the group injected with BCG after 8 weeks.
2) All the groups injected with IMAMURA strain vaccine have showed a smaller leproma compared to the untreated control. Some inhibition of growth was apparent even in the group injected after 8 weeks.
3) Examination of the bacillary distribution in lymphnodes showed little difference between the BCG injected, IMAMURA vaccine injected and the control groups. Examination of bacillary distribution in the organs however showed that in the IMAMURA vaccine injected group, bacilli were totally absent, showing that a definite inhibition had taken place.
The results suggest that injection of BCG vaccine or IMAMURA strain tubercle bacilli vaccine at a set inoculation of rats with murine leprosy bacilli, is effective in inhibiting
